SENSUS HEALTHCARE INC (SRTS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SRTS - US81728J1097 - Common Stock

4.83 USD

-0.14 (-2.82%)

Last: 1/23/2026, 8:00:00 PM

Fundamental Rating

Taking everything into account, SRTS scores 5 out of 10 in our fundamental rating. SRTS was compared to 184 industry peers in the Health Care Equipment & Supplies industry. While SRTS has a great health rating, there are worries on its profitability. SRTS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

SRTS had negative earnings in the past year.
SRTS had a positive operating cash flow in the past year.
SRTS had positive earnings in 4 of the past 5 years.
SRTS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of -5.16%, SRTS is doing good in the industry, outperforming 66.85% of the companies in the same industry.
SRTS has a better Return On Equity (-5.87%) than 70.11% of its industry peers.

		Industry Rank	Sector Rank
ROA	-5.16%
ROE	-5.87%
ROIC	N/A

ROA(3y)18.11%

ROA(5y)8.54%

ROE(3y)21.11%

ROE(5y)9.47%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SRTS's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of SRTS has grown nicely.
Looking at the Gross Margin, with a value of 47.95%, SRTS is in line with its industry, outperforming 41.85% of the companies in the same industry.
SRTS's Gross Margin has declined in the last couple of years.
SRTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	47.95%

OM growth 3Y8.29%

OM growth 5YN/A

PM growth 3Y1.43%

PM growth 5YN/A

GM growth 3Y-2.39%

GM growth 5Y-1.93%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SRTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SRTS has more shares outstanding
The number of shares outstanding for SRTS remains at a similar level compared to 5 years ago.
There is no outstanding debt for SRTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 8.12 indicates that SRTS is not in any danger for bankruptcy at the moment.
SRTS's Altman-Z score of 8.12 is amongst the best of the industry. SRTS outperforms 86.96% of its industry peers.
There is no outstanding debt for SRTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	8.12

ROIC/WACCN/A

WACC10.02%

2.3 Liquidity

SRTS has a Current Ratio of 7.38. This indicates that SRTS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.38, SRTS belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
SRTS has a Quick Ratio of 5.27. This indicates that SRTS is financially healthy and has no problem in meeting its short term obligations.
SRTS's Quick ratio of 5.27 is amongst the best of the industry. SRTS outperforms 83.15% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.38
Quick Ratio	5.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SRTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -133.33%.
SRTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.56% yearly.
The Revenue for SRTS has decreased by -13.80% in the past year. This is quite bad
Measured over the past years, SRTS shows a quite strong growth in Revenue. The Revenue has been growing by 8.93% on average per year.

EPS 1Y (TTM)-133.33%

EPS 3Y18.56%

EPS 5YN/A

EPS Q2Q%-185.71%

Revenue 1Y (TTM)-13.8%

Revenue growth 3Y15.63%

Revenue growth 5Y8.93%

Sales Q2Q%-22.12%

3.2 Future

The Earnings Per Share is expected to grow by 11.64% on average over the next years. This is quite good.
SRTS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.67% yearly.

EPS Next Y-187.55%

EPS Next 2Y-46.73%

EPS Next 3Y-29.92%

EPS Next 5Y11.64%

Revenue Next Year-22.05%

Revenue Next 2Y0.32%

Revenue Next 3Y6.2%

Revenue Next 5Y14.67%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRTS. In the last year negative earnings were reported.
Also next year SRTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SRTS is valued a bit cheaper than the industry average as 77.17% of the companies are valued more expensively.